Assignee
LAYTON MARK E
US·3 granted patents·4 pending applications·1 citations·filing 2005–2012
Top patents by PatentIndex Score
7 records- 0162US9273040B2Benzoxazolinone compounds with selective activity in voltage-gated sodium channelsLAYTON MARK E·Filed 2012·Granted Mar 1, 2016·1 cites·22 claims
- 0247US2010022573A1Inhibitors of akt activityLAYTON MARK E·Filed 2007·Application pending·0 cites
- 0343US2009124600A1N-Alkyl-Azacycloalkyl NMDA/NR2B AntagonistsLAYTON MARK E·Filed 2006·Application pending·0 cites
- 0442US2013035332A1Substituted 1,3-Benzothiazol-2(3H)-Ones and [1,3]Thiazolo[5,4-B]Pyridin-2(IH)-Ones as Positive Allosteric Modulators of MGLUR2LAYTON MARK E·Filed 2011·Application pending·0 cites
- 0538US8481503B2Combination cancer therapy with an AKT inhibitor and other anticancer agentsLAYTON MARK E·Filed 2010·Granted Jul 9, 2013·0 cites·5 claims
- 0638US2007293515A11,3-Disubstituted Heteroaryl Nmda/Nr2b AntagonistsLAYTON MARK E·Filed 2005·Application pending·0 cites
- 0734US9108937B2Positive allosteric modulators of mGluR2LAYTON MARK E·Filed 2011·Granted Aug 18, 2015·0 cites·26 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →